Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase-Reference-Cited by-同舟云学术

Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase

Published:2017-10 Issue: Volume:13 Page:655-664
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Chang Kwang-Yu,Hsu Tsung-I.,Hsu Che-Chia,Tsai Shan-Yin,Liu Jr-Jiun,Chou Shao-Wen,Liu Ming-Sheng,Liou Jing-Ping,Ko Chiung-Yuan,Chen Kai-Yun,Hung Jan-Jong,Chang Wen-Chang,Chuang Cheng-Keng,Kao Tzu-Jen,Chuang Jian-Ying

Funder

National Health Research Institutes

Ministry of Science and Technology, Taiwan

Taipei Medical University

Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference45 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009

2. Activation of amp-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition;Zhang;J. Biol. Chem.,2010